Low dose AKT inhibitor miransertib cures PI3K-related vascular malformations in preclinical models of human disease
Piotr Kobialka(Goethe University Frankfurt), Mariona Graupera(Josep Carreras Leukaemia Research Institute)
Cited by 6
Related Papers
Resistance to Antiangiogenic Therapies by Metabolic Symbiosis in Renal Cell Carcinoma PDX Models and Patients
|Cell Reports|2016|119
PTEN mediates Notch-dependent stalk cell arrest in angiogenesis
|Nature Communications|2015|109
ALK1 Loss Results in Vascular Hyperplasia in Mice and Humans Through PI3K Activation
|Arteriosclerosis Thrombosis and Vascular Biology|2018|104
Resistance to Targeted Therapies in Renal Cancer: The Importance of Changing the Mechanism of Action
|Targeted Oncology|2016|103